A comparison of genetic risk score with family history for estimating prostate cancer risk

by Brian T Helfand
Published 2016-01-01

Clinical validity and utility of genetic risk scores in prostate cancer

by Brian T Helfand, James Kearns, Carly Conran, Jianfeng Xu
Published 2016-01-01

Bladder Pneumatosis From a Catastrophic Vascular Event

by Ian J. Cooke, Leslie M. Okorji, Richard S. Matulewicz, Daniel T. Oberlin, Brian T. Helfand
Published 2016-09-01

Serum Total Testosterone and Premature Mortality Among Men in the USA

by Richard J. Fantus, Cecilia Chang, Elizabeth A. Platz, Nelson E. Bennett, Brian T. Helfand, Robert E. Brannigan, Joshua A. Halpern
Published 2021-07-01

Assessing the clinical utility of genetic risk scores for targeted cancer screening

by Carly A. Conran, Zhuqing Shi, William Kyle Resurreccion, Rong Na, Brian T. Helfand, Elena Genova, Siqun Lilly Zheng, Charles B. Brendler, Jianfeng Xu
Published 2021-01-01

Systematic evaluation of cancer‐specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts

by Zhuqing Shi, Hongjie Yu, Yishuo Wu, Xiaoling Lin, Quanwa Bao, Haifei Jia, Chelsea Perschon, David Duggan, Brian T. Helfand, Siqun L. Zheng, Jianfeng Xu
Published 2019-06-01

Genetic Susceptibility for Low Testosterone in Men and Its Implications in Biology and Screening: Data from the UK Biobank

by Richard J. Fantus, Rong Na, Jun Wei, Zhuqing Shi, W. Kyle Resurreccion, Joshua A. Halpern, Omar Franco, Simon W. Hayward, William B. Isaacs, S. Lilly Zheng, Jianfeng Xu, Brian T. Helfand
Published 2021-07-01

Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter stud...

by Da Huang, Yi-Shuo Wu, Ding-Wei Ye, Jun Qi, Fang Liu, Brian T Helfand, Siqun L Zheng, Qiang Ding, Dan-Feng Xu, Rong Na, Jian-Feng Xu, Ying-Hao Sun
Published 2020-01-01

Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study.

by Hemant K Roy, Charles B Brendler, Hariharan Subramanian, Di Zhang, Charles Maneval, John Chandler, Leah Bowen, Karen L Kaul, Brian T Helfand, Chi-Hsiung Wang, Margo Quinn, Jacqueline Petkewicz, Michael Paterakos, Vadim Backman
Published 2015-01-01

A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate Cancer

by Shane M. Pearce, MD, Chi‐Hsiung E. Wang, PhD, David E. Victorson, PhD, Brian T. Helfand, MD, PhD, Kristian R. Novakovic, MD, Charles B. Brendler, MD, Jeffrey A. Albaugh, PhD, APRN
Published 2015-09-01

Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases

by Rong Na, Dingwei Ye, Jun Qi, Fang Liu, Xiaoling Lin, Brian T Helfand, Charles B Brendler, Carly Conran, Jian Gong, Yishuo Wu, Xu Gao, Yaqing Chen, S Lilly Zheng, Zengnan Mo, Qiang Ding, Yinghao Sun, Jianfeng Xu
Published 2016-01-01

Examining Online Traffic Patterns to Popular Direct-To-Consumer Websites for Evaluation and Treatment of Erectile Dysfunction

by Joel J. Wackerbarth, MD, Richard J. Fantus, MD, Annie Darves-Bornoz, MD, Marah C. Hehemann, MD, Brian T. Helfand, MD, PhD, Mary Kate Keeter, MPH, Robert E. Brannigan, MD, Nelson E. Bennett, MD, Joshua A. Halpern, MD, MS
Published 2021-02-01

TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence.

by Qiang Zhang, Lin Chen, Brian T Helfand, Thomas L Jang, Vidit Sharma, James Kozlowski, Timothy Michael Kuzel, Lihua J Zhu, Ximing J Yang, Borko Javonovic, Yinglu Guo, Scott Lonning, Jay Harper, Beverly A Teicher, Charles Brendler, Nengwang Yu, William J Catalona, Chung Lee
Published 2011-01-01